Safety of human blood products in rare bleeding disorders in southeast of Iran

Haemophilia

Volumn 19, Issue 2, 2013, Pages

  Naderi, M ^a   Eshghi, P ^b,d   Saneei Moghaddam, E ^c   Alizadeh, Sh ^d   Dorgalaleh, A ^d   Younesi, M R ^d   Khateb, Z K ^d  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

BLEEDING DISORDER; BLOOD; BLOOD TRANSFUSION; CONSANGUINEOUS MARRIAGE; CRYOPRECIPITATE; EPISTAXIS; GINGIVA BLEEDING; HUMAN; IRAN; LETTER; ORAL BLEEDING; PLASMAPHERESIS; PRIORITY JOURNAL; PRODUCT SAFETY;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMORRHAGIC DISORDERS; HUMANS; INFANT; IRAN; MALE; MIDDLE AGED; PATIENT SAFETY; PLASMA; RARE DISEASES; VIRUS DISEASES; YOUNG ADULT;

EID: 84874109899     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12068     Document Type: Letter

References (10)

1. Peyvandi F, Kaufman RJ, Seligsohn U et al. Rare bleeding disorders. Haemophilia 2006; 12(Suppl. 3): 137-42.
2. Acharya SS, Coughlin A, Dimichele DM, North American Rare Bleeding Disorder Study G. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2: 248-56.
3. Peyvandi F, Spreafico M. National and international registries of rare bleeding disorders. Blood transfus = Trasfusione del sangue. 2008; 6(Suppl. 2): s45-8.
4. Iorio A, Basileo M, Marchesini E et al. Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. Blood transfus = Trasfusione del sangue. 2008; 6: 211-9.
5. Benjamin RJ, McLaughlin LS. Plasma components: properties, differences, and uses. Transfusion 2012; 52(Suppl. 1): 9S-19S.
6. Yatuv R, Robinson M, Dayan-Tarshish I, Baru M. The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia. Int J Nanomed 2010; 5: 581-91.
7. Heim MU, Hellstern P, Bundesarztekammer fur die H. [New cross-sectional guidelines of the German Medical Association for hemotherapy with fresh frozen plasma. Evidence-based recommendations for risk-benefit assessment]. Anaesthesist 2010; 59: 80-5. Neue (Querschnitt-)Leitlinien der Bundesarztekammer fur die Hamotherapie mit gefrorenem Frischplasma. Evidenzbasierte Empfehlungen fur die Risiko-Nutzen-Abwagung.
8. Santoro C, Goldberg I, Bridey F et al. Successful hip arthroplasty in an adult male with severe factor XI deficiency using Hemoleven(R), a factor XI concentrate. Haemophilia 2011; 17: 777-82.
9. Pasmant E, Dumont B, Lacapere JJ, Dautzenberg MD, Bezeaud A. A severe neonatal presentation of factor II deficiency. Eur J Haematol 2011; 87: 464-6.
10. Aynaoglu G, Durdag GD, Ozmen B, Soylemez F. Successful treatment of hereditary factor VII deficiency presented for the first time with epistaxis in pregnancy: a case report. J Matern Fetal Neonatal Med 2010; 23: 1053-5.